title: Genetically modified Shiga toxin 2e (Stx2e) producing Escherichia coli is a vaccine candidate for porcine edema disease.
abstract: Porcine edema disease (ED) is an enterotoxaemia in pigs after weaning, caused by Shiga toxin 2e (Stx2e) producing Escherichia coli. Recently in Japan, outbreaks of ED are re-emerging in pig production. In this study we constructed a mutant that retained immunogenicity but lost Vero cell cytotoxicity, which produced genetically modified toxin (Stx2e*) by replacing glutamate with glutamine at position 167 and arginine with leucine at position 170 of the A subunit. The stx(2e)* gene was replaced with the stx(2e)gene of the wild type virulent strain by homologous recombination. As the parent wild strain was pathogenic to pigs but the mutant was not, the mutant named as YT106 was given to the pigs to examine its protective immunity against ED. All 20 pigs vaccinated with YT106 survived, but only eight of the 20 non-vaccinated pigs survived after the challenge with a wild strain. Also, the eight pigs that survived had decreased rates of gain relative to those of the controls. Blood IgG and intestinal IgA titres increased 3.3 and 1.6 times more than the control, respectively, showing that YT106 might be a good candidate of a live attenuated vaccine strain to protect against ED.
authors: Department of Veterinary Microbiology, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan. smakino@obihiro.ac.jp
authors: S
authors: S
authors: Makino
authors: M
authors: M
authors: Watarai
authors: H
authors: H
authors: Tabuchi
authors: T
authors: T
authors: Shirahata
authors: H
authors: H
authors: Furuoka
authors: Y
authors: Y
authors: Kobayashi
authors: Y
authors: Y
authors: Takeda
mesh_terms: D000818:Animals; D001428:Bacterial Vaccines / Q000235:genetics / Q000276:immunology*; D002522:Chlorocebus aethiops; D004488:Edema Disease of Swine / Q000473:pathology / Q000517:prevention & control*; D004926:Escherichia coli / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D016297:Mutagenesis, Site-Directed; D022641:Shiga Toxin 2 / Q000235:genetics / Q000276:immunology*; D013552:Swine; D014614:Vaccines, Synthetic / Q000235:genetics / Q000276:immunology*; D014709:Vero Cells
chemical_list: D001428:Bacterial Vaccines; D022641:Shiga Toxin 2; D014614:Vaccines, Synthetic